{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:50:59Z","timestamp":1792144259635,"version":"4.4.0"},"reference-count":85,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,10,14]],"date-time":"2027-10-14T00:00:00Z","timestamp":1823472000000},"content-version":"am","delay-in-days":347,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA263806S1"],"award-info":[{"award-number":["R01CA263806S1"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016393","name":"Center for Medicinal Cannabis Research, University of California, San Diego","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016393","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["1K01DK143205-01"],"award-info":[{"award-number":["1K01DK143205-01"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpet.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.jpet.2026.105037","type":"journal-article","created":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T23:12:25Z","timestamp":1790291545000},"page":"105037","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Antinociceptive interaction of \u03949-tetrahydrocannabinol and cannabidiol in a humanized mouse model of sickle cell disease"],"prefix":"10.1016","volume":"393","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3986-8344","authenticated-orcid":false,"given":"Alex","family":"Mabou Tagne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4277-3859","authenticated-orcid":false,"given":"Olufunke Florence","family":"Ajeigbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-4994-9252","authenticated-orcid":false,"given":"Heidi C.","family":"Avalos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7543-9945","authenticated-orcid":false,"given":"Francesca","family":"Galvani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Al Masri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Mireles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalpna","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Piomelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4 Suppl","key":"10.1016\/j.jpet.2026.105037_bib1","doi-asserted-by":"crossref","first-page":"S512","DOI":"10.1016\/j.amepre.2009.12.022","article-title":"Population estimates of sickle cell disease in the U.S","volume":"38","author":"Hassell","year":"2010","journal-title":"Am J Prev Med"},{"issue":"11","key":"10.1016\/j.jpet.2026.105037_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0079923","article-title":"Severe painful vaso-occlusive crises and mortality in a contemporary adult sickle cell anemia cohort study","volume":"8","author":"Darbari","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.jpet.2026.105037_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2019.134471","article-title":"Updated mechanisms underlying sickle cell disease-associated pain","volume":"712","author":"Du","year":"2019","journal-title":"Neurosci Lett"},{"issue":"2865","key":"10.1016\/j.jpet.2026.105037_bib4","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1126\/science.110.2865.543","article-title":"Sickle cell anemia, a molecular disease","volume":"110","author":"Pauling","year":"1949","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.jpet.2026.105037_bib5","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/0022-2836(85)90175-5","article-title":"Kinetics of sickle hemoglobin polymerization. II. A double nucleation mechanism","volume":"183","author":"Ferrone","year":"1985","journal-title":"J Mol Biol"},{"issue":"5","key":"10.1016\/j.jpet.2026.105037_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2022.103533","article-title":"Acute and chronic pain management in patients with sickle cell disease in the modern era: a comprehensive review","volume":"61","author":"Tolu","year":"2022","journal-title":"Transfus Apher Sci"},{"issue":"4","key":"10.1016\/j.jpet.2026.105037_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094387","article-title":"Outcomes of acute chest syndrome in adult patients with sickle cell disease: predictors of mortality","volume":"9","author":"Allareddy","year":"2014","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.jpet.2026.105037_bib8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/ajh.20336","article-title":"Hospital readmission for adult acute sickle cell painful episodes: frequency, etiology, and prognostic significance","volume":"79","author":"Ballas","year":"2005","journal-title":"Am J Hematol"},{"issue":"23","key":"10.1016\/j.jpet.2026.105037_bib9","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1056\/NEJM199406093302303","article-title":"Mortality in sickle cell disease. Life expectancy and risk factors for early death","volume":"330","author":"Platt","year":"1994","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jpet.2026.105037_bib10","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/ejh.14211","article-title":"Sickle Cell Health Awareness, Perspectives, and Experiences (SHAPE) survey: perspectives of adolescent and adult patients, caregivers, and healthcare professionals on the burden of sickle cell disease","volume":"113","author":"de Montalembert","year":"2024","journal-title":"Eur J Haematol"},{"issue":"2","key":"10.1016\/j.jpet.2026.105037_bib11","doi-asserted-by":"crossref","first-page":"94","DOI":"10.7326\/0003-4819-148-2-200801150-00004","article-title":"Daily assessment of pain in adults with sickle cell disease","volume":"148","author":"Smith","year":"2008","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.jpet.2026.105037_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.1567","article-title":"Sickle cell disease in Grenada: quality of life and barriers to care","volume":"9","author":"Grygiel","year":"2021","journal-title":"Mol Genet Genomic Med"},{"issue":"2","key":"10.1016\/j.jpet.2026.105037_bib13","doi-asserted-by":"crossref","first-page":"46","DOI":"10.14740\/jh828","article-title":"Opioid use in adults with sickle cell disease hospitalized during vaso-occlusive crisis: a systematic review","volume":"10","author":"Osborne","year":"2021","journal-title":"J Hematol"},{"issue":"4","key":"10.1016\/j.jpet.2026.105037_bib14","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/bjh.15169","article-title":"Pain and opioid use after reversal of sickle cell disease following HLA-matched sibling haematopoietic stem cell transplant","volume":"184","author":"Darbari","year":"2019","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.jpet.2026.105037_bib15","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.bbmt.2018.11.027","article-title":"Haploidentical bone marrow transplantation with post-transplantation cyclophosphamide plus thiotepa improves donor engraftment in patients with sickle cell anemia: results of an international learning collaborative","volume":"25","author":"de la Fuente","year":"2019","journal-title":"Biol Blood Marrow Transplant"},{"issue":"18","key":"10.1016\/j.jpet.2026.105037_bib16","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1056\/NEJMoa2309676","article-title":"Exagamglogene autotemcel for severe sickle cell disease","volume":"390","author":"Frangoul","year":"2024","journal-title":"N Engl J Med"},{"issue":"24","key":"10.1016\/j.jpet.2026.105037_bib17","doi-asserted-by":"crossref","first-page":"6481","DOI":"10.1182\/bloodadvances.2025016701","article-title":"Improvements in health-related quality of life in patients with severe sickle cell disease after exagamglogene autotemcel","volume":"9","author":"Sharma","year":"2025","journal-title":"Blood Adv"},{"issue":"4","key":"10.1016\/j.jpet.2026.105037_bib18","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1182\/bloodadvances.2024013693","article-title":"Is allogeneic transplantation for sickle cell disease still relevant in the era of gene therapy?","volume":"9","author":"Jones","year":"2025","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.jpet.2026.105037_bib19","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.clpt.2003.10.007","article-title":"Systemic exposure to morphine and the risk of acute chest syndrome in sickle cell disease","volume":"75","author":"Kopecky","year":"2004","journal-title":"Clin Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.jpet.2026.105037_bib20","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1093\/bja\/aet221","article-title":"Morphine stimulates platelet-derived growth factor receptor-\u03b2 signalling in mesangial cells in vitro and transgenic sickle mouse kidney in vivo","volume":"111","author":"Weber","year":"2013","journal-title":"Br J Anaesth"},{"issue":"6","key":"10.1016\/j.jpet.2026.105037_bib21","doi-asserted-by":"crossref","first-page":"F1388","DOI":"10.1152\/ajprenal.00389.2007","article-title":"Morphine induces mesangial cell proliferation and glomerulopathy via kappa-opioid receptors","volume":"294","author":"Weber","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"issue":"10","key":"10.1016\/j.jpet.2026.105037_bib22","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2014.10517","article-title":"Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members","volume":"312","author":"Yawn","year":"2014","journal-title":"JAMA"},{"issue":"16","key":"10.1016\/j.jpet.2026.105037_bib23","doi-asserted-by":"crossref","first-page":"3814","DOI":"10.1182\/bloodadvances.2020002325","article-title":"Medical marijuana certification for patients with sickle cell disease: a report of a single center experience","volume":"4","author":"Curtis","year":"2020","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.jpet.2026.105037_bib24","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1089\/can.2018.0001","article-title":"Marijuana use in adults living with sickle cell disease","volume":"3","author":"Roberts","year":"2018","journal-title":"Cannabis Cannabinoid Res"},{"issue":"Suppl 1","key":"10.1016\/j.jpet.2026.105037_bib25","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1097\/j.pain.0000000000002268","article-title":"Cannabinoids, the endocannabinoid system, and pain: a review of preclinical studies","volume":"162","author":"Finn","year":"2021","journal-title":"Pain"},{"issue":"8","key":"10.1016\/j.jpet.2026.105037_bib26","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.7326\/M21-4520","article-title":"Cannabis-based products for chronic pain: a systematic review","volume":"175","author":"McDonagh","year":"2022","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.jpet.2026.105037_bib27","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1146\/annurev-pharmtox-052220-021800","article-title":"Endocannabinoid-based therapies","volume":"62","author":"Piomelli","year":"2022","journal-title":"Ann Rev Pharmacol Toxicol"},{"key":"10.1016\/j.jpet.2026.105037_bib28","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/bs.apha.2017.05.003","article-title":"Cannabinoids and pain: sites and mechanisms of action","volume":"80","author":"Starowicz","year":"2017","journal-title":"Adv Pharmacol"},{"issue":"3","key":"10.1016\/j.jpet.2026.105037_bib29","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1182\/blood-2010-01-260372","article-title":"Pain-related behaviors and neurochemical alterations in mice expressing sickle hemoglobin: modulation by cannabinoids","volume":"116","author":"Kohli","year":"2010","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.jpet.2026.105037_bib30","doi-asserted-by":"crossref","first-page":"566","DOI":"10.3324\/haematol.2015.136523","article-title":"Cannabinoid receptor-specific mechanisms to alleviate pain in sickle cell anemia via inhibition of mast cell activation and neurogenic inflammation","volume":"101","author":"Vincent","year":"2016","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.jpet.2026.105037_bib31","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1124\/jpet.124.002285","article-title":"\u03949-tetrahydrocannabinol alleviates hyperalgesia in a humanized mouse model of sickle cell disease","volume":"391","author":"Mabou Tagne","year":"2024","journal-title":"J Pharmacol Exp Ther"},{"issue":"7","key":"10.1016\/j.jpet.2026.105037_bib32","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/j.1476-5381.2011.01238.x","article-title":"Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects","volume":"163","author":"Russo","year":"2011","journal-title":"Br J Pharmacol"},{"issue":"8","key":"10.1016\/j.jpet.2026.105037_bib33","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.3390\/ijms20081833","article-title":"A novel standardized Cannabis sativa L. extract and its constituent cannabidiol inhibit human polymorphonuclear leukocyte functions","volume":"20","author":"Mabou Tagne","year":"2019","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.jpet.2026.105037_bib34","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1182\/blood.2022016382","article-title":"Cannabidiol attenuates hyperalgesia in a mouse model of sickle cell disease","volume":"141","author":"Cherukury","year":"2023","journal-title":"Blood"},{"issue":"5339","key":"10.1016\/j.jpet.2026.105037_bib35","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1126\/science.278.5339.876","article-title":"Transgenic knockout mice with exclusively human sickle hemoglobin and sickle cell disease","volume":"278","author":"P\u00e1szty","year":"1997","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.jpet.2026.105037_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/cpns.54","article-title":"Mouse models of pain in sickle cell disease","volume":"85","author":"Sagi","year":"2018","journal-title":"Curr Protoc Neurosci"},{"key":"10.1016\/j.jpet.2026.105037_bib37","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.euroneuro.2021.07.007","article-title":"Frequent \u03949- tetrahydrocannabinol exposure during adolescence impairs sociability in adult mice exposed to an aversive painful stimulus","volume":"53","author":"Mabou Tagne","year":"2021","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.jpet.2026.105037_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105545","article-title":"Palmitoylethanolamide and hemp oil extract exert synergistic anti-nociceptive effects in mouse models of acute and chronic pain","volume":"167","author":"Mabou Tagne","year":"2021","journal-title":"Pharmacol Res"},{"issue":"6","key":"10.1016\/j.jpet.2026.105037_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0039765","article-title":"A novel behavioral assay for measuring cold sensation in mice","volume":"7","author":"Brenner","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jpet.2026.105037_bib40","article-title":"Administration of \u03949-tetrahydrocannabinol (THC) in adolescent and adult mice","volume":"222","author":"Jung","year":"2025","journal-title":"J Vis Exp"},{"issue":"3","key":"10.1016\/j.jpet.2026.105037_bib41","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1124\/jpet.121.000740","article-title":"Persistent exposure to \u03949-tetrahydrocannabinol during adolescence does not affect nociceptive responding in adult mice","volume":"378","author":"Mabou Tagne","year":"2021","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"10.1016\/j.jpet.2026.105037_bib42","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1038\/s41467-024-46139-5","article-title":"NAAA-regulated lipid signaling in monocytes controls the induction of hyperalgesic priming in mice","volume":"15","author":"Fotio","year":"2024","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.jpet.2026.105037_bib43","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.biopsych.2022.04.017","article-title":"Frequent low-dose \u03949-tetrahydrocannabinol in adolescence disrupts microglia homeostasis and disables responses to microbial infection and social stress in young adulthood","volume":"92","author":"Lee","year":"2022","journal-title":"Biol Psychiatry"},{"issue":"9","key":"10.1016\/j.jpet.2026.105037_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.116261","article-title":"Metabolic reprogramming in the spinal cord drives the transition to pain chronicity","volume":"44","author":"Mabou Tagne","year":"2025","journal-title":"Cell Rep"},{"issue":"43","key":"10.1016\/j.jpet.2026.105037_bib45","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abi8834","article-title":"NAAA-regulated lipid signaling governs the transition from acute to chronic pain","volume":"7","author":"Fotio","year":"2021","journal-title":"Sci Adv"},{"key":"10.1016\/j.jpet.2026.105037_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2022.114194","article-title":"Synergistic antinociceptive effects of concomitant NAAA and peripheral FAAH inhibition","volume":"357","author":"Mabou Tagne","year":"2022","journal-title":"Exp Neurol"},{"issue":"1","key":"10.1016\/j.jpet.2026.105037_bib47","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/jpet.106.104117","article-title":"An overview of drug combination analysis with isobolograms","volume":"319","author":"Tallarida","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jpet.2026.105037_bib48","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aea8738","article-title":"Metabolic reallocation in spinal cord oligodendrocytes drives chronic pain in mice through neuronal A\u03b242 production","volume":"18","author":"Fotio","year":"2026","journal-title":"Sci Transl Med"},{"issue":"7\u20138","key":"10.1016\/j.jpet.2026.105037_bib49","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1159\/000524753","article-title":"Diet-induced obesity disrupts histamine-dependent oleoylethanolamide signaling in the mouse liver","volume":"107","author":"Lin","year":"2022","journal-title":"Pharmacology"},{"issue":"6","key":"10.1016\/j.jpet.2026.105037_bib50","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/nprot.2008.73","article-title":"Analyzing real-time PCR data by the comparative C(T) method","volume":"3","author":"Schmittgen","year":"2008","journal-title":"Nat Protoc"},{"issue":"6","key":"10.1016\/j.jpet.2026.105037_bib51","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1023\/B:BILE.0000019559.84305.47","article-title":"Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper\u2013Excel-based tool using pair-wise correlations","volume":"26","author":"Pfaffl","year":"2004","journal-title":"Biotechnol Lett"},{"issue":"7","key":"10.1016\/j.jpet.2026.105037_bib52","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1007\/s00213-023-06358-y","article-title":"Fatty acid amide hydrolase inhibition alleviates anxiety-like symptoms in a rat model used to study post-traumatic stress disorder","volume":"242","author":"Fotio","year":"2025","journal-title":"Psychopharmacology (Berl)"},{"issue":"26","key":"10.1016\/j.jpet.2026.105037_bib53","doi-asserted-by":"crossref","DOI":"10.1523\/JNEUROSCI.1322-24.2025","article-title":"Microglia support both the singular form of LTP expressed by the lateral perforant path and episodic memory","volume":"45","author":"Chavez","year":"2025","journal-title":"J Neurosci"},{"issue":"4","key":"10.1016\/j.jpet.2026.105037_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpet.2026.104308","article-title":"Pharmacokinetic and pharmacodynamic properties of cannabigerol in male mice","volume":"393","author":"Mabou Tagne","year":"2026","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jpet.2026.105037_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106600","article-title":"Nasal accumulation and metabolism of \u03949-tetrahydrocannabinol following aerosol (\u201cvaping\u201d) administration in an adolescent rat model","volume":"187","author":"Torrens","year":"2023","journal-title":"Pharmacol Res"},{"issue":"6","key":"10.1016\/j.jpet.2026.105037_bib56","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1089\/can.2024.0076","article-title":"Comparative pharmacokinetics of \u03949-tetrahydrocannabinol in adolescent and adult female mice","volume":"9","author":"Torrens","year":"2024","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1016\/j.jpet.2026.105037_bib57","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.nbd.2015.10.004","article-title":"Cognitive and behavior deficits in sickle cell mice are associated with profound neuropathologic changes in hippocampus and cerebellum","volume":"85","author":"Wang","year":"2016","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.jpet.2026.105037_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcmd.2023.102776","article-title":"Mouse models of sickle cell disease: imperfect and yet very informative","volume":"104","author":"Kamimura","year":"2024","journal-title":"Blood Cells Mol Dis"},{"issue":"5","key":"10.1016\/j.jpet.2026.105037_bib59","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1111\/bjh.18981","article-title":"Psychiatric comorbidities in adults with sickle cell disease: a narrative review","volume":"203","author":"Mishkin","year":"2023","journal-title":"Br J Haematol"},{"issue":"47","key":"10.1016\/j.jpet.2026.105037_bib60","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000036147","article-title":"Psychosocial challenges of persons with sickle cell anemia: a narrative review","volume":"102","author":"Essien","year":"2023","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"10.1016\/j.jpet.2026.105037_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpain.2024.104603","article-title":"Unmet need: mechanistic and translational studies of sickle cell disease pain as a whole-person health challenge","volume":"25","author":"Belfer","year":"2024","journal-title":"J Pain"},{"issue":"10","key":"10.1016\/j.jpet.2026.105037_bib62","doi-asserted-by":"crossref","first-page":"5780","DOI":"10.1073\/pnas.96.10.5780","article-title":"Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice","volume":"96","author":"Zimmer","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"10.1016\/j.jpet.2026.105037_bib63","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1182\/bloodadvances.2024015439","article-title":"Neuroprotective, anti-inflammatory, and analgesic activity of palmitoylethanolamide in sickle cell mice","volume":"9","author":"Argueta","year":"2025","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.jpet.2026.105037_bib64","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1089\/can.2019.0052","article-title":"Use of cannabidiol for the treatment of anxiety: a short synthesis of pre-clinical and clinical evidence","volume":"5","author":"Wright","year":"2020","journal-title":"Cannabis Cannabinoid Res"},{"issue":"1","key":"10.1016\/j.jpet.2026.105037_bib65","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00213-020-05712-8","article-title":"Cannabidiol: pharmacology and therapeutic targets","volume":"238","author":"Britch","year":"2021","journal-title":"Psychopharmacology (Berl)"},{"issue":"Suppl 1","key":"10.1016\/j.jpet.2026.105037_bib66","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1097\/j.pain.0000000000001929","article-title":"Cannabinoids, cannabis, and cannabis-based medicine for pain management: a systematic review of randomised controlled trials","volume":"162","author":"Fisher","year":"2021","journal-title":"Pain"},{"issue":"1","key":"10.1016\/j.jpet.2026.105037_bib67","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/bph.13333","article-title":"Neural correlates of interactions between cannabidiol and \u0394(9)-tetrahydrocannabinol in mice: implications for medical cannabis","volume":"173","author":"Todd","year":"2016","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.jpet.2026.105037_bib68","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/npp.2017.209","article-title":"Clinical and preclinical evidence for functional interactions of cannabidiol and \u03949-tetrahydrocannabinol","volume":"43","author":"Boggs","year":"2018","journal-title":"Neuropsychopharmacology"},{"issue":"18","key":"10.1016\/j.jpet.2026.105037_bib69","doi-asserted-by":"crossref","first-page":"4261","DOI":"10.1111\/bph.15181","article-title":"Interactions between cannabidiol and \u03949-tetrahydrocannabinol in modulating seizure susceptibility and survival in a mouse model of Dravet syndrome","volume":"177","author":"Anderson","year":"2020","journal-title":"Br J Pharmacol"},{"issue":"2","key":"10.1016\/j.jpet.2026.105037_bib70","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1007\/s00213-011-2342-0","article-title":"Cannabidiol potentiates \u03949-tetrahydrocannabinol (THC) behavioural effects and alters THC pharmacokinetics during acute and chronic treatment in adolescent rats","volume":"218","author":"Klein","year":"2011","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.jpet.2026.105037_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115665","article-title":"Mechanisms of cannabinoid tolerance","volume":"214","author":"Piscura","year":"2023","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"10.1016\/j.jpet.2026.105037_bib72","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1089\/can.2021.0185","article-title":"The relationship between circulating endogenous cannabinoids and the effects of smoked cannabis","volume":"8","author":"Kearney-Ramos","year":"2023","journal-title":"Cannabis Cannabinoid Res"},{"key":"10.1016\/j.jpet.2026.105037_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108394","article-title":"Inhibiting degradation of 2-arachidonoylglycerol as a therapeutic strategy for neurodegenerative diseases","volume":"244","author":"Chen","year":"2023","journal-title":"Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.jpet.2026.105037_bib74","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/ajh.22012","article-title":"Oxidative stress in sickle cell disease; pathophysiology and potential implications for disease management","volume":"86","author":"Nur","year":"2011","journal-title":"Am J Hematol"},{"issue":"7","key":"10.1016\/j.jpet.2026.105037_bib75","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23294","article-title":"Correlation of lipid peroxidation and nitric oxide metabolites, trace elements, and antioxidant enzymes in patients with sickle cell disease","volume":"34","author":"Antwi-Boasiako","year":"2020","journal-title":"J Clin Lab Anal"},{"issue":"2","key":"10.1016\/j.jpet.2026.105037_bib76","doi-asserted-by":"crossref","first-page":"296","DOI":"10.3390\/antiox10020296","article-title":"Sickle cell disease: role of oxidative stress and antioxidant therapy","volume":"10","author":"Vona","year":"2021","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.jpet.2026.105037_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2020.104686","article-title":"Interleukin-1 receptor antagonist ameliorates the pain hypersensitivity, spinal inflammation and oxidative stress induced by systemic lipopolysaccharide in neonatal rats","volume":"135","author":"Hsieh","year":"2020","journal-title":"Neurochem Int"},{"issue":"11","key":"10.1016\/j.jpet.2026.105037_bib78","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/1873-3468.14864","article-title":"Caspase-3 targets pro-interleukin-1\u03b2 (IL-1\u03b2) to restrict inflammation","volume":"598","author":"Kim","year":"2024","journal-title":"FEBS Lett"},{"issue":"3","key":"10.1016\/j.jpet.2026.105037_bib79","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1074\/jbc.M109.069294","article-title":"Cannabinoids delta(9)-tetrahydrocannabinol and cannabidiol differentially inhibit the lipopolysaccharide-activated NF-kappaB and interferon-beta\/STAT proinflammatory pathways in BV-2 microglial cells","volume":"285","author":"Kozela","year":"2010","journal-title":"J Biol Chem"},{"issue":"13","key":"10.1016\/j.jpet.2026.105037_bib80","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.3390\/molecules28134991","article-title":"The anti-inflammatory effects of cannabis sativa extracts on LPS-induced cytokines release in human macrophages","volume":"28","author":"Zaiachuk","year":"2023","journal-title":"Molecules"},{"issue":"6","key":"10.1016\/j.jpet.2026.105037_bib81","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2012.71","article-title":"Cannabidiol protects oligodendrocyte progenitor cells from inflammation-induced apoptosis by attenuating endoplasmic reticulum stress","volume":"3","author":"Mecha","year":"2012","journal-title":"Cell Death Dis"},{"issue":"12","key":"10.1016\/j.jpet.2026.105037_bib82","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.4049\/jimmunol.2000213","article-title":"Activation of CB1R promotes lipopolysaccharide-induced IL-10 secretion by monocytic myeloid-derived suppressive cells and reduces acute inflammation and organ injury","volume":"204","author":"Joffre","year":"2020","journal-title":"J Immunol"},{"key":"10.1016\/j.jpet.2026.105037_bib83","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.921493","article-title":"Potency and therapeutic THC and CBD ratios: U.S. cannabis markets overshoot","volume":"13","author":"Pennypacker","year":"2022","journal-title":"Front Pharmacol"},{"issue":"11","key":"10.1016\/j.jpet.2026.105037_bib84","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1111\/bcp.13710","article-title":"The pharmacokinetics and the pharmacodynamics of cannabinoids","volume":"84","author":"Lucas","year":"2018","journal-title":"Br J Clin Pharmacol"},{"issue":"7","key":"10.1016\/j.jpet.2026.105037_bib85","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.10874","article-title":"Effect of inhaled cannabis for pain in adults with sickle cell disease: a randomized clinical trial","volume":"3","author":"Abrams","year":"2020","journal-title":"JAMA Netw Open"}],"container-title":["The Journal of Pharmacology and Experimental Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526012371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022356526012371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:42:31Z","timestamp":1792143751000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022356526012371"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":85,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S0022356526012371"],"URL":"https:\/\/doi.org\/10.1016\/j.jpet.2026.105037","relation":{},"ISSN":["0022-3565"],"issn-type":[{"value":"0022-3565","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antinociceptive interaction of \u03949-tetrahydrocannabinol and cannabidiol in a humanized mouse model of sickle cell disease","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pharmacology and Experimental Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpet.2026.105037","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 American Society for Pharmacology and Experimental Therapeutics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105037"}}